Ovid Therapeutics Inc. (1OT)
XDUS
Real-time Data
06:00 AM
Day's Range
2.0852 wk Range
0.9800Overview - 1OT - Ovid Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
266.00K
P/E (Trailing)
‪-9.65‬
PEG Ratio
‪-0.28‬
Price / Book
‪2.08‬
EV / EBITDA
‪-0.0063‬
Profitability
Operating Margin
‪-585.20%‬
Return on Assets
‪-11.53%‬
Return on Equity
‪-13.32%‬
Ownership
Shares Outstanding
184.75M
Price stats
50-Day Avg
‪2.19‬
200-Day Avg
‪1.86‬
Peers - 1OT - Ovid Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 1OTXDUSOvid Therapeutics Inc.+54.05%52-week change-9.65P/E (Trailing)—Profit Margin
- 0QFXDUSModerna Inc.+85.69%52-week change—P/E (Trailing)—Profit Margin
- 2LBXDUSIovance Biotherapeutics Inc.+83.47%52-week change-10.55P/E (Trailing)‪34.27%‬Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+82.13%52-week change-37.88P/E (Trailing)—Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- 42ZXDUSRevolution Medicines, Inc.+78.13%52-week change-30.44P/E (Trailing)—Profit Margin
- 3O8XDUSOmeros Corp.+77.85%52-week change-333.00P/E (Trailing)—Profit Margin
Profile Summary - 1OT - Ovid Therapeutics Inc.
About
Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing small molecule medicines for brain disorders, with an emphasis on epilepsies and other seizure-related neurological conditions. The company’s current pipeline centers on therapies designed to address significant unmet needs in central nervous…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
